期刊文献+

流式细胞术检测P选择素的方法学性能评价 被引量:1

The evaluation of the methodology for the determination of P selectin with flow cytometry
下载PDF
导出
摘要 目的对流式细胞术(FCM)检测P选择素进行方法学性能评价。方法参考美国临床和实验室标准化协会(CLSI)系列文件,结合工作实际,设计验证方案,对BD Aria流式细胞仪检测系统测定血浆P选择素的精密度、准确度、分析灵敏度、分析测量范围和生物可参考区间五大分析性能进行验证和评价,并将实验结果与厂家(美国BD公司)提供的分析性能或公认的质量指标进行比较。结果 P选择素含量在39.06和10 000 ng/L时,批内变异系数分别为4.23%和9.00%,批间变异系数分别为4.63%和11.00%,准确度相对偏倚分别为2.71%和5.28%;检测灵敏度为7.88 ng/L,分析测量范围为7.88-103 928.00 ng/L,生物参考区间验证为4 512.20-10 250.00 ng/L。结论 BD Aria流式细胞仪检测系统检测血浆P选择素的分析性能符合厂家提供的性能指标和公认的质量指标。 Objective To evaluate the performance of flow cytometry(FCM) methodology to test P-selectin.Methods Referring to a series of documents by the U.S.Institute of Clinical and Laboratory Standards(CLSI),as well as practical experience,we designed the plan to test and analyze the BD Aria FCM on precision,accuracy,analytical sensitivity,analytical measurement range and biological reference interval,and then compared the experiment results with the parameters provided by the manufacturer(U.S.BD company) or publicly acknowledged quality standards.Results When the content of P-selectin level was between 39.06 ng / L and 10 000 ng / L,the intraassay coefficient of variation was between 4.23% and 9.00%,while the interassay coefficient of variation was between 4.63% and 11.00%.The relative bias of accuracy of the two was 2.71% and 5.28% respectively.The test sensitivity was 7.88 ng / L.The domain of the analysis and measurement was 7.88-103 928.00 ng/L,while the validation of biological reference interval was 4 512.20-10 250.00 ng/L.Conclusion The performance of BD Aria FCM analysis system to test plasma P-selectin is in accordance with the parameters provided by the manufacturer as well as publicly acknowledged quality parameters.
出处 《检验医学与临床》 CAS 2011年第7期792-793,795,共3页 Laboratory Medicine and Clinic
关键词 流式细胞术 方法学评价 P选择素 FCM evaluation methodology P-selectin
  • 相关文献

参考文献5

二级参考文献23

  • 1潘柏申,张万忠,陈铭生,郭玮,周华文,倪星忠.上海地区血清丙氨酸转氨酶测定结果一致性和参考范围调查[J].检验医学,2005,20(5):417-420. 被引量:11
  • 2丛玉隆.加强检验科与临床交流促进检验科与临床结合[J].中华检验医学杂志,2006,29(1):2-5. 被引量:116
  • 3申子瑜,李少男,王治国.我国政府对临床实验室质量保证的管理行为[J].中华检验医学杂志,2006,29(1):6-8. 被引量:24
  • 4中国实验室国家认可委员会.中国实验室注册评审员培训教程[M].北京:中国标准出版社,2001.08..
  • 5卫生部.医疗机构临床实验室管理办法.2006-02-27.
  • 6卫生部办公厅.卫生部办公厅关于医疗机构间医学检验、医学影像检查互认有关问题的通知.2006-02-28.
  • 7国际标准化组织.ISO 9000:2000质量管理体系-理论基础和术语.2000.
  • 8Maynard JH.The regulation of medical laboratories in Australia.Clin Lab Med,1991,11:777-791.
  • 9Huisman W.European Communities Confederation of Clinical Chemistry Working Group on Accreditation:past,present and future.Clin Chim Acta,2001,309:111-114.
  • 10Haeney MR,Blair C.Raising standards in pathology:the accreditation process in the United Kingdom.J Qual Clin Pract,1998,18:75-82.

共引文献72

同被引文献7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部